Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共4页
• 作者

  Zinzani Pier Luigi; Santoro Armando; Mollica Luigina; Leppa Sirpa; Follows George A.; Lenz Georg; Kim Won Seog; Nagler Arnon; Panayiotidis Panayiotis; Demeter Judit; Morschhauser Franck; Rodrigues Liana; Reeves John; Hiemeyer Florian; Miriyala Ashok; Garcia-Vargas Jose; Childs Barrett H.; Dreyling Martin H.;

  展开▼
• 作者单位

  Univ Bologna Inst Hematol Seragnoli Bologna Italy;

  IRCCS Humanitas Inst Med Oncol Milan Italy;

  Maisonneuve Rosemont Hosp Res Ctr Montreal PQ Canada;

  Univ Helsinki Hosp Canc Ctr Helsinki Finland;

  Cambridge Univ Hosp NHS Trust Cambridge England;

  Univ Hosp Munster Translat Oncol Munster Germany;

  Sungkyunkwan Univ Sch Med Samsung Med Ctr Seoul South Korea;

  Tel Aviv Univ Chaim Sheba Med Ctr Tel Hashomer Israel;

  Univ Athens Sch Med Athens Greece;

  Semmelweis Univ Budapest Hungary;

  CHRU Hop Claude Huriez Lille France;

  Bayer SA Sao Paulo Brazil;

  Joule INC Edison NJ USA;

  Bayer AG Pharmaceut Div Berlin Germany;

  Bayer HealthCare Pharmaceut Whippany NJ USA;

  Bayer HealthCare Pharmaceut Whippany NJ USA;

  Bayer HealthCare Pharmaceut Whippany NJ USA;

  Klinikum Univ Munchen Grosshadern Med Klin &

  Poliklin 3 Munich Germany;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词